UNICREDIT BANK/CALL/PFIZER INC/28/0.1/19.06.24 | Market Closed - Borsa Italiana 04:04:59 2024-05-17 pm EDT | ||
| 0.1035 EUR | -20.69% |
|
| Current month | +220.63% | ||
| 1 month | +201.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 0.1035 | -20.69% |
| 24-05-16 | 0.1305 | +6.97% |
| 24-05-15 | 0.122 | +24.49% |
| 24-05-14 | 0.098 | -4.85% |
| 24-05-13 | 0.103 | +27.95% |
Real-time Borsa Italiana
Last update May 17, 2024 at 04:04 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
UniCredit
|
| UD1FCP | |
| ISIN | DE000HD1FCP8 |
| Date issued | 2023-12-27 |
| Strike | 28 $ |
| Maturity | 2024-06-19 (33 Days) |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.333 € |
|---|---|
| Lowest since issue | 0.0235 € |
| Spread | 0.001 € |
| Spread % | 0.98% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.92
USD
Average target price
31.94
USD
Spread / Average Target
+10.44%
- Stock Market
- Warrants
- UD1FCP Warrant
